Bilateral Acute Retinal Necrosis Treated With Antivirals and Corticosteroids.

Autor:	Ramirez Marquez E; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Santiago A; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Mendez I; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Santiago JC; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., López-Fontanet JJ; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Garcia N; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA., Oliver AL; Ophthalmology, University of Puerto Rico School of Medicine, Medical Sciences Campus, San Juan, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Oct 21; Vol. 15 (10), pp. e47427. Date of Electronic Publication: 2023 Oct 21 (Print Publication: 2023).
DOI:	10.7759/cureus.47427
Abstrakt:	We report on the case of a Hispanic male with bilateral acute retinal necrosis (BARN), whose disease was managed with intravenous acyclovir, topical prednisolone, topical atropine, intravitreal ganciclovir, oral valacyclovir, and oral prednisone. The oral corticosteroid was added to his treatment regimen eight days after his initial presentation. The 55-year-old patient presented with a two-week history of bilateral blurred vision. His medical history was pertinent for remote varicella and herpes zoster (the latter limited to the forehead). His best-corrected visual acuity (BCVA) was counting fingers in both eyes (OU). His examination was remarkable in OU for grade 3+ cells, pharmacologically dilated pupils, and grade 2+ vitreous cells. The patient's fundus was remarkable in OU for optic-nerve swelling, vitreous condensation, ghost vessels, and retinitis patches. Given the clinical and ancillary testing results, an assessment of BARN was made. The patient received acyclovir treatment initially, and systemic steroids were introduced eight days later. He ultimately experienced significant clinical improvement. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Ramirez Marquez et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu